Intervention not reported
Patients having voice disturbance at 2 weeks · adults with acute laryngitis
The intervention showed no clear difference in patients having voice disturbance at 2 weeks (low certainty).
1 finding from 1 review
Intervention not reported
Frequency of meningitis · patients with a recent BSF independent of the presence or severity of CSF leakage
The intervention showed no clear difference in frequency of meningitis (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · patients with a recent BSF independent of the presence or severity of CSF leakage
The intervention showed no clear difference in all‐cause mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Meningitis‐related mortality · patients with a recent BSF independent of the presence or severity of CSF leakage
The intervention showed no clear difference in meningitis‐related mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Need for surgical correction in patients with CSF leakage · patients with a recent BSF independent of the presence or severity of CSF leakage
1 finding from 1 review
Intervention not reported
Non‐CNS infection · patients with a recent BSF independent of the presence or severity of CSF leakage
The intervention showed no clear difference in non‐CNS infection (high certainty).
1 finding from 1 review
Intervention not reported
All cause mortality · cancer patients receiving myelotoxic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Incidence of febrile neutropenia · cancer patients receiving myelotoxic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Incidence of severe infections (Grade III or IV) · cancer patients receiving myelotoxic chemotherapy
The intervention showed no clear difference in incidence of severe infections (Grade III or IV) (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events Toxic deaths · cancer patients receiving myelotoxic chemotherapy
The intervention showed no clear difference in adverse events Toxic deaths (low certainty).
1 finding from 1 review
Intervention not reported
Infection‐related mortality · cancer patients receiving myelotoxic chemotherapy
1 finding from 1 review
Intervention not reported
Quality of life · cancer patients receiving myelotoxic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Incidence of febrile neutropenia · cancer patients receiving myelotoxic chemotherapy
It is very uncertain whether the intervention changes incidence of febrile neutropenia (very low certainty).
1 finding from 1 review
Intervention not reported
Incidence of severe infections · cancer patients receiving myelotoxic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · cancer patients receiving myelotoxic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All cause mortality · cancer patients receiving myelotoxic chemotherapy
1 finding from 1 review
Intervention not reported
Infection‐related mortality · cancer patients receiving myelotoxic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life · cancer patients receiving myelotoxic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of subjects who developed symptomatic UTI (6 months to 1 year) · adults with asymptomatic bacteriuria
The intervention showed no clear difference in number of subjects who developed symptomatic UTI (6 months to 1 year) (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of subjects who developed complications (10 months to 3 years) · adults with asymptomatic bacteriuria
The intervention showed no clear difference in number of subjects who developed complications (10 months to 3 years) (moderate certainty).
1 finding from 1 review